BATON ROUGE, La., April 24, 2018 -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice and personal care company, announced today that Sharon Brunecz will join the Company as Chief Human Resources Officer, replacing Chief Human Resources Officer Larry Pernosky who has announced his retirement.
With more than 20 years of experience, Brunecz is an expert in leading human capital strategies that drive business outcomes including talent management, total rewards, organizational and leadership development, employee engagement, talent acquisition, metrics and analytics, and merger and acquisitions.
Most recently, Brunecz served as Chief Human Resources Officer for US Acute Care Solutions (USACS), the nation's leading physician-owned provider of integrated acute care services offering emergency, hospitalist and observation medicine to hospital partners providing care to 6 million patients annually at over 200 sites in 22 states. In this role, she had overall accountability for Human Resources, Corporate Communications and Marketing functions. Prior to USACS, Brunecz held several HR leadership positions with PNC Financial Services Group.
“Our employees are at the heart of everything we do here at Amedisys,” stated President and Chief Executive Officer Paul Kusserow. “Sharon’s depth of expertise in human capital strategies will be invaluable as we continue our quest in becoming the industry’s employer of choice to attract and retain the best of the best to care for our patients.”
“I would also like to recognize the many contributions that Larry Pernosky has made during his tenure at Amedisys. I want to give my sincere thanks for his leadership in helping to transform our Company’s culture, and wish him the very best in his well-deserved retirement.”
About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. We partner with 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 17,500 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 369,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact:
Kendra Kimmons
Vice President of Marketing & Communications
225-299-3708
[email protected]


Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial 



